NanoVibronix Announces Selection of Leading International Contract Manufacturer to Support Rapid Scale-up, Lower Price Points and Enhance Profitability
December 11, 2018 09:01 ET
|
NanoVibronix, Inc.
ELMSFORD, N.Y., Dec. 11, 2018 (GLOBE NEWSWIRE) -- NanoVibronix, Inc, (NASDAQ: NAOV), a medical device company utilizing the Company's proprietary and patented low intensity surface acoustic wave...
NanoVibronix Announces Publication of Study Measuring the Effect of Surface Acoustic Waves on Bacterial Load and Preventing Catheter-Associated Urinary Tract Infections
December 06, 2018 08:00 ET
|
NanoVibronix, Inc.
UroShield™ reduced Colony Forming Units (CFU) count from >100,000 to 10,000 CFU or less in 25 of 29 patients in the treatment group No reported infections in the treatment group versus 27%...
NanoVibronix Provides Business Update for the Third Quarter of 2018
November 14, 2018 08:00 ET
|
NanoVibronix, Inc.
Lays out key upcoming milestones for the next 12 months ELMSFORD, N.Y., Nov. 14, 2018 (GLOBE NEWSWIRE) -- NanoVibronix, Inc, (NASDAQ: NAOV), a medical device company utilizing the Company's...
NanoVibronix to Present at Dawson James Securities 4th Annual Small Cap Growth Conference
October 22, 2018 16:47 ET
|
NanoVibronix, Inc.
ELMSFORD, N.Y., Oct. 22, 2018 (GLOBE NEWSWIRE) -- NanoVibronix, Inc., (NASDAQ: NAOV), a medical device company utilizing the Company’s proprietary and patented low intensity surface acoustic wave...
NanoVibronix Provides Business Update for the Second Quarter of 2018
August 16, 2018 08:00 ET
|
NanoVibronix, Inc.
Revenue increases 153% for the second quarter of 2018 ELMSFORD, N.Y., Aug. 16, 2018 (GLOBE NEWSWIRE) -- NanoVibronix, Inc, (NASDAQ: NAOV), a medical device company utilizing the Company's...
NanoVibronix Reports Successful Trial Results for Use of PainShield™ in Patients with Trigeminal Neuralgia; Reinforces Potential as Alternative to Opioids and Surgical Interventions
July 24, 2018 07:30 ET
|
NanoVibronix, Inc.
ELMSFORD, N.Y., July 24, 2018 (GLOBE NEWSWIRE) -- NanoVibronix, Inc, (NASDAQ:NAOV), a medical device company utilizing the Company's proprietary and patented low intensity surface acoustic wave...
NanoVibronix Announces Exclusive Agreement for Distribution of PainShield® and WoundShield® in Israel
June 05, 2018 07:00 ET
|
NanoVibronix, Inc.
ELMSFORD, N.Y., June 05, 2018 (GLOBE NEWSWIRE) -- NanoVibronix, Inc., (NASDAQ:NAOV), a medical device company utilizing the Company’s proprietary and patented low intensity surface acoustic wave...
NanoVibronix Provides Business Update for the First Quarter 2018
May 17, 2018 09:44 ET
|
NanoVibronix, Inc.
ELMSFORD, N.Y., May 17, 2018 (GLOBE NEWSWIRE) -- NanoVibronix, Inc, (NASDAQ:NAOV), a medical device company utilizing the Company's proprietary and patented low intensity surface acoustic wave (SAW)...
NanoVibronix Partners with Fabrication Enterprises, Inc. for Distribution of PainShield® in the United States
May 09, 2018 07:00 ET
|
NanoVibronix, Inc.
ELMSFORD, N.Y., May 09, 2018 (GLOBE NEWSWIRE) -- NanoVibronix, Inc., (NASDAQ:NAOV), a medical device company utilizing the Company’s proprietary and patented low intensity surface acoustic wave...
NanoVibronix to Present at the 3rd Annual Disruptive Growth & Healthcare Conference Hosted by RHK Capital and Reed Smith
May 01, 2018 08:39 ET
|
NanoVibronix, Inc.
NEW YORK, May 01, 2018 (GLOBE NEWSWIRE) -- NanoVibronix, Inc., (NASDAQ:NAOV), a medical device company utilizing the Company’s proprietary and patented low intensity surface acoustic wave (SAW)...